Annual report pursuant to Section 13 and 15(d)

DEBT - Components of Debt (Details)

v3.22.1
DEBT - Components of Debt (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Jul. 19, 2021
Debt Instrument [Line Items]      
Total debt, current portion $ 17,508 $ 880  
Total debt, long term 7,587 32,963  
Ending balance 25,095 33,843  
Debt amortization costs 4,227 426 [1]  
Convertible notes      
Debt Instrument [Line Items]      
Debt issuance costs, net   741  
Convertible Note due 2024      
Debt Instrument [Line Items]      
Debt issuance costs and debt discount     $ 965
Debt issuance costs, net     $ 630
Convertible Note due 2024 | Convertible notes      
Debt Instrument [Line Items]      
Total debt, long term 1,140 0  
Convertible Note due 2024 | Convertible notes      
Debt Instrument [Line Items]      
Total debt, current portion 16,559 0  
Debt issuance costs and debt discount 2,197    
Herbal Brands Loan due May 2023      
Debt Instrument [Line Items]      
Total debt, current portion 470 880  
Total debt, long term 4,760 5,191  
Debt amortization costs 410    
Other loans and borrowings      
Debt Instrument [Line Items]      
Total debt, current portion 479 0  
Total debt, long term 1,687 630  
Series D Convertible Note due March 2022 | Convertible notes      
Debt Instrument [Line Items]      
Total debt, long term 0 $ 27,142  
Write off of unamortized debt financing cost $ 483    
[1] The Company reclassified $426 debt issuance amortization, reported in previous period in other-noncash expense, net to debt issuance amortization, to conform to the current period presentation.